MicroRNA-disease Network Analysis Repurposes Methotrexate for the Treatment of Abdominal Aortic Aneurysm in Mice
MicroRNA-disease Network Analysis Repurposes Methotrexate for the Treatment of Abdominal Aortic Aneurysm in Mice
复制标题
MicroRNA-疾病网络分析重新利用甲氨蝶呤治疗小鼠腹主动脉瘤
DOI:
10.1016/j.gpb.2022.08.002
复制
发表时间:
2024-03-01
影响因子:
9.5
通讯作者:
Cui,Qinghua
中科院分区:
文献类型:
--
作者:
Shen,Yicong;Gao,Yuanxu;Cui,Qinghua
Abdominal aortic aneurysm(AAA) is a permanent dilatation of the abdominal aorta and is highly lethal. The main purpose of the current study is to search for noninvasive medical therapies for AAA, for which there is currently no effective drug therapy.Network medicinerepresents a cutting-edge technology, as analysis and modeling of disease networks can provide critical clues regarding the etiology of specific diseases and therapeutics that may be effective. Here, we proposed a novel algorithm to quantify disease relations based on a large accumulated microRNA–disease association dataset and then built a disease network covering 15 disease classes and 304 diseases. Analysis revealed some patterns for these diseases. For instance, diseases tended to be clustered and coherent in the network. Surprisingly, we found that AAA showed the strongest similarity with rheumatoid arthritis and systemic lupus erythematosus, both of which areautoimmune diseases, suggesting that AAA could be one type of autoimmune diseases in etiology. Based on this observation, we further hypothesized that drugs for autoimmune diseases could be repurposed for the prevention and therapy of AAA. Finally, animal experiments confirmed thatmethotrexate, a drug for autoimmune diseases, was able to alleviate the formation and development of AAA.